[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Timothy Mullett\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":104},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,41,60,79],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100641198","kentucky---quality-improvement-implementation-lung-cancer-screening-quils-implementation-100641198",false,"NCT07639255","Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation","Statewide Optimization of Lung Cancer Screening Utilizing the QUILS System","Inclusion Criteria:\n\n* Participants in Lung Cancer Screening Program, including physicians, nurses, administrators and other staff responsible for the conduct of the program.\n* Willing to participate in the QUILS Index Assessment Survey process\n* Willing to participate in the QUILS Audit Feedback presentations Willing to participate in formative evaluation interviews\n\nExclusion Criteria:\n\n* Unwilling to participate in the QUILS Index Assessment Survey process\n* Unwilling to participate in the QUILS Audit Feedback presentations\n* Unwilling to participate in formative evaluation interviews","ALL","18 Years","100 Years",{"count":20,"type":21},330,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.",[27],"Lung Cancer Screening","RECRUITING","2026-06-27",{"date":31,"type":32},"2026-07-01","ACTUAL",{"date":34,"type":32},"2025-04-01",{"date":36,"type":21},"2028-06-01",{"name":38,"class":39},"Timothy Mullett","OTHER",17,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":58,"leadSponsor":59,"locationsCount":40},"100646994","kentucky---quality-improvement-implementation-lung-cancer-screening-quils-health-services-research-intervention-100646994","NCT07682610","Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention","Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System (Kentucky QUILS™ Implementation): HSR Intervention","Inclusion Criteria:\n\n* Member of a participating Lung Cancer Screening Program (LCSP) team or administrator\n* Willing to participate in the QUILS Index Assessment Survey process\n* Willing to participate in the QUILS Audit Feedback presentations\n* Willing to participate in formative evaluation interviews\n\nExclusion Criteria:\n\n* Unwilling to participate in the QUILS Index Assessment Survey process\n* Unwilling to participate in the QUILS Audit Feedback presentations\n* Unwilling to participate in formative evaluation interviews",true,{"count":50,"type":21},35500,[24],"This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.",[27],"2026-06-26",{"date":56,"type":32},"2026-07-06",{"date":34,"type":32},{"date":36,"type":21},{"name":38,"class":39},{"id":61,"slug":62,"hasResults":11,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":4,"eligibilityCriteria":66,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":67,"targetDuration":4,"studyType":22,"phases":69,"briefSummary":70,"conditions":71,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":72,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},"100646993","statewide-optimization-of-lung-cancer-screening-utilizing-the-quils-system-in-nevada-and-mississippi-state-based-initiative-component-100646993","NCT07682597","Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component","Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based","Inclusion Criteria:\n\n* Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.\n* Leadership member of the Mississippi state team or Nevada state team\n* Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)\n* Willing to participate in study-related assessments an implementation activities\n\nExclusion Criteria:\n\n* None",{"count":68,"type":21},200,[24],"This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.",[27],{"date":56,"type":32},{"date":74,"type":32},"2026-03-01",{"date":76,"type":21},"2029-07-01",{"name":38,"class":39},13,{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":85,"targetDuration":4,"studyType":22,"phases":87,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},"100541185","comprehensive-connected-cancer-care-c4-intervention-evaluation-100541185","NCT06326567","Comprehensive Connected Cancer Care (C4): Intervention Evaluation","Inclusion Criteria:\n\n* Patients with newly diagnosed or recurrent cancer who have not initiated treatment of any kind, including surgery, medical management, and\u002For radiation\n* Patients with one reported social determinants of health (SDOH) need OR patients at high-risk for SDOH needs based on demographic information (racial \\& ethnic minorities, medicaid\u002Funinsured populations).\n* Willingness to provide informed consent to participate\n\nExclusion Criteria:\n\n* Not able to understand and communicate in English\n* Unable and\u002For unwilling to access the internet on a phone, tablet, or computer",{"count":86,"type":21},300,[24],"The C4 program aims to provide a multi-level intervention program (Patient Level, Healthcare Team and Healthcare System Level) that improves the coordination of care with supportive\u002Fancillary care providers and community services through the use of patient navigation and a digital needs assessment and a closed-loop referral system and improves patient-centered communication and engagement in care through skills training for the healthcare team and provision of culturally appropriate patient educational tools and resources. The program components incorporate three areas that are critical to improving patient-centered care: coordination of care, patient-centered communication and engagement, and psychosocial care and other supportive services.",[90,91],"Cancer","Health Care Utilization",[93,94],"Community Programs","Health Equity","2026-06-17",{"date":97,"type":32},"2026-06-22",{"date":99,"type":32},"2024-02-01",{"date":101,"type":21},"2027-12",{"name":38,"class":39},1,""]